Tcr2 Therapeutics Inc (TCRR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | TCRR | PRPH | MURA | ||
Company | Tcr2 Therapeutics Inc | Prophase Labs Inc | Mural Oncology Plc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 1.5800 | 3.13 | 3.44 | ||
High | 1.6300 | 3.27 | 3.44 | ||
Low | 1.4800 | 3.06 | 3.32 | ||
Last | 1.4800 | 3.11 | 3.39 | ||
Change | -0.0900 | -0.01 | -0.04 | ||
% Change | -5.73% | -0.32% | -1.17% | ||
Volume | 3,913,300 | 30,700 | 67,800 | ||
20-Day Average Volume | 474,175 | 32,335 | 322,540 | ||
Previous Close | 1.5700 | 3.12 | 3.43 | ||
Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
Has Options | No | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 1.8315 | 3.62 | 3.20 | ||
20-Day Raw Stochastic | 0.00% | 3.49% | 80.95% | ||
20-Day Relative Strength | 35.83% | 28.36% | 51.76% | ||
Weighted Alpha | -29.20 | -57.30 | -38.06 | ||
Today's Opinion | 8% Buy | 88% Sell | N/A | ||
Previous Opinion | 24% Buy | 88% Sell | N/A | ||
Last Month's Opinion | 56% Buy | 56% Sell | N/A | ||
Performance | |||||
5-Days | |||||
%Chg | -14.45% since 05/23/23 | -3.42% since 07/15/24 | +2.42% since 07/15/24 | ||
Low | 1.4800 on 05/31/23 | 3.06 on 07/22/24 | 3.28 on 07/16/24 | ||
High | 1.7800 on 05/24/23 | 3.43 on 07/17/24 | 3.51 on 07/18/24 | ||
1-Month | |||||
%Chg | -16.15% since 04/28/23 | -29.16% since 06/21/24 | +4.63% since 06/21/24 | ||
Low | 1.4800 on 05/31/23 | 3.06 on 07/22/24 | 2.88 on 07/05/24 | ||
High | 2.0400 on 05/08/23 | 4.49 on 06/24/24 | 3.51 on 07/18/24 | ||
3-Month | |||||
%Chg | +18.40% since 02/28/23 | -36.53% since 04/22/24 | -5.57% since 04/22/24 | ||
Low | 1.1521 on 03/03/23 | 3.06 on 07/22/24 | 2.88 on 07/05/24 | ||
High | 2.0400 on 05/08/23 | 5.62 on 05/06/24 | 4.18 on 05/15/24 | ||
6-Month | |||||
%Chg | +13.85% since 11/28/22 | -39.14% since 01/22/24 | -22.78% since 01/22/24 | ||
Low | 0.8210 on 12/23/22 | 3.06 on 07/22/24 | 2.88 on 07/05/24 | ||
High | 2.0400 on 05/08/23 | 7.48 on 04/16/24 | 5.62 on 03/08/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 58,108 | 59,526 | 58,049 | ||
Shares Outstanding, K | 39,262 | 19,079 | 16,924 | ||
Annual Sales | 0 | 44,380,000 | 0 | ||
Annual Net Income | -151,820,000 | -16,780,000 | -207,450,000 | ||
Last Quarter Sales | 0 | 3,630,000 | 0 | ||
Last Quarter Net Income | -40,400,000 | -6,270,000 | -30,920,000 | ||
60-Month Beta | 1.94 | -0.10 | N/A | ||
Per-Share Information | |||||
Most Recent Earnings | -1.03 on 05/11/23 | -0.07 on 05/09/24 | -1.84 on 05/14/24 | ||
Latest Earnings Date | 05/11/23 | 08/08/24 | 08/13/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |